Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Evogene (EVGN) EPS (Weighted Average and Diluted) (2020 - 2024)

Historic EPS (Weighted Average and Diluted) for Evogene (EVGN) over the last 9 years, with Q4 2024 value amounting to $0.07.

  • Evogene's EPS (Weighted Average and Diluted) rose 10521.08% to $0.07 in Q4 2024 from the same period last year, while for Dec 2024 it was $0.07, marking a year-over-year increase of 10521.08%. This contributed to the annual value of -$2.89 for FY2024, which is 4435.57% up from last year.
  • As of Q4 2024, Evogene's EPS (Weighted Average and Diluted) stood at $0.07, which was up 10521.08% from -$2977.5 recorded in Q2 2024.
  • Evogene's EPS (Weighted Average and Diluted)'s 5-year high stood at $21002.4 during Q2 2022, with a 5-year trough of -$2977.5 in Q2 2024.
  • Over the past 5 years, Evogene's median EPS (Weighted Average and Diluted) value was -$0.51 (recorded in 2020), while the average stood at $1976.7.
  • As far as peak fluctuations go, Evogene's EPS (Weighted Average and Diluted) plummeted by 29705.52% in 2022, and later surged by 10521.08% in 2024.
  • Quarter analysis of 5 years shows Evogene's EPS (Weighted Average and Diluted) stood at -$0.29 in 2020, then skyrocketed by 36.8% to -$0.18 in 2021, then plummeted by 297.06% to -$0.72 in 2022, then crashed by 98.71% to -$1.44 in 2023, then skyrocketed by 105.21% to $0.07 in 2024.
  • Its last three reported values are $0.07 in Q4 2024, -$2977.5 for Q2 2024, and -$1.44 during Q4 2023.